Top 30 Biotech Companies of 2023

The biotech industry is a rapidly growing sector that is constantly pushing the boundaries of what is possible in healthcare and medicine. 

With breakthroughs in genetic engineering, gene therapy, and personalized medicine, biotech companies are driving innovation and improving the lives of millions around the world. 

In this article, we will look at the top 30 biotech companies of 2023, highlighting the key players, their achievements, and contributions to the industry while discussing the market capital and company size for a few. 

The data is based on the latest official financial reports of the companies.

1. Novo Nordisk A/S (NVO)

Novo Nordisk CEO: Lars Fruergaard Jørgensen Founded In: December 21, 1923 Headquarters: Bagsværd, Denmark Market Capital: 239.65 billion (usd) Company Status: Publicly traded company Number of employees: 48,478 (end 2021)
Biotech Company (Novo Nordisk)

Novo Nordisk A/S (NVO)

CEO:  Lars Fruergaard Jørgensen

Founded In: December 21, 1923

Headquarters: Bagsværd, Denmark

Market Capital: 239.65 billion (USD)

Company Status: Publicly traded company

Number of employees: 48,478 (end 2021)

Novo Nordisk is a Danish company established in 1923 that is famous for its diabetes care, hemophilia care, growth hormone therapy, and hormone replacement therapy. With a large company size and currently employing more than 50,000 employees, Novo Nordisk has a total market capitalization of $317.35 Billion as of January 2023 and a revenue in 2022 (TTM) of $23.96 Billion.

2. Thermo Fisher Scientific

Biotech Company Thermo Fisher Scientific
CEO: Marc N. Casper
Founded In: 1956
Headquarters: Waltham, Massachusetts, United States
Market Capital: 224.98 billion
Company Status: Publicly traded company
Number of employees: 130,000 (dec 2021)
Biotech Company (Thermo Fisher Scientific)

CEO: Marc N. Casper

Founded In: 1956

Headquarters: Waltham, Massachusetts, United States

Market Capital: 224.98 billion

Company Status: Publicly traded company

Number of employees: 130,000 (Dec 2021)

Thermo Fisher Scientific is an American company established in 1956 that is famous for its scientific instruments, reagents, and consumables for research and diagnostics. With an enormous company size and 130,000 employees, Thermo Fisher Scientific has a total market capital of $232.83 billion and total annual revenue in 2022 (TTM) of $44.16 Billion.

3. Amgen

CEO: Robert A. Bradway

Founded In: April 8, 1980

Headquarters: Thousand Oaks, California, United States

Market Capital: 135.34 billion

Company Status: Publicly traded company

Number of employees: 24,200 (2022)

Amgen is an American company established in 1980 that is famous for its oncology, inflammation, and bone health. With a large company size and retaining more than 25,000 employees, Amgen has a total market capitalization of $140.46 billion and a TTM revenue in 2022 of $26.33 Billion. A core strategy of the company is to develop innovative, highly differentiated medicines that are highly effective in addressing serious diseases ”. 

4. Gilead Sciences

CEO: Daniel O’Day

Founded In: June 22, 1987

Headquarters: Foster City, California, United States

Market Capital: 105.02 billion

Company Status: Publicly traded company

Number of employees: 14,400 (2022)

Gilead Sciences is an American biopharmaceutical company established in 1987 that is famous for its antiviral therapies for HIV, hepatitis B and C, and influenza. With a large company size and more than 16,000 employees, Gilead Sciences has a total market capitalization of $104.11 billion as of Jan 2023. Under the supervision of Micheal L. Riordan, the founder, the company achieved a profit of $20.248 billion at its year-end 30 September 2022.

5. CSL Limited

CEO: Paul Perreault

Founded In: 1916

Headquarters: Melbourne, Australia

Market Capital: 100.8 billion usd

Company Status: Publicly traded company

Number of employees: 30,000 (2022)

CSL Limited is an Australian company established in 1916 that is famous for its blood plasma products, vaccines, and therapies. Specifically, they focus on rare and serious diseases; influenza vaccines; iron deficiency, and nephrology. With a large company size and 30,000 employees, CSL Limited had a total market capitalization of $94.06 billion as of 2022.

6. Moderna Inc. (MRNA)

CEO: Stéphane Bancel

Founded In: September 2010

Headquarters: Cambridge, Massachusetts, United States

Market Capital: 72.74 billion

Company Status: Publicly traded company

Number of employees: 3,700 (Sept 2022)

Moderna Inc. is an American company established in 2010 that is famous for its messenger RNA (mRNA) therapeutics and vaccines. With an amazing team of 3900 members and 12-plus years of progress, Moderna has delivered greatest possible impact through mRNA medicines in the medical field. The total market capitalization of Moderna is $74.52 billion as of Jan 2023.

7. BioNTech SE (BNTX)

CEO: Uğur Şahin

Founded In: 2008

Headquarters: Germany

Market Capital: 2.86 billion USD

Company Status: Publicly Traded Company

Number of employees: 4,000 (2022)

BioNTech SE is a German company established in 2008 that is famous for its personalized cancer vaccines and therapies. BioNTech SE was the one of few biotech companies to develop a COVID-19 vaccine in 2020 creating history in medicine as the fastest vaccine developed against a new pathogen. The BioNTech team has collaborated and advanced a lot in their long career having 11 pipelines in the preclinical phase, 16 in phase 1, 5 in phase 2, and 1 in phase 3 as of now.

8. Regeneron Pharmaceuticals Inc. (REGN)

CEO: Leonard Schleifer

Founded In: 1988

Headquarters: Tarrytown, New York, United States

Market Capital: 80.90 billion

Company Status: Publicly traded company

Number of employees: 10,915 (2022)

Regeneron Pharmaceuticals Inc. is an American company established in 1988 that is famous for its therapies for eye diseases, cancer, and other inflammatory conditions. On its 30-plus-year journey, Regeneron has employed 10,915 employees and gained $78.63 billion of market capitalization. With its continuous development and progress, Regeneron has a long list of FD-approved treatments and products under its homegrown laboratories.

9. Vertex Pharmaceuticals Inc. (VRTX)

Vertex Pharmaceuticals Inc. is an American company established in 1989 that is famous for its therapies for cystic fibrosis (CF).  With 20-plus years of research on creating innovative medicines, Vertex guarantees itself that it can treat up to 90% of all people with cystic fibrosis. A mid-size company and 3,900 employees, Vertex  Pharmaceuticals Inc. has a total market capitalization of $79.53 billion.

10. Jazz Pharmaceuticals PLC (JAZZ)

CEO: Bruce C. Cozadd

Founded In: March 2005

Headquarters: Ireland

Market Capital: 9.80 billion USD

Company Status: Publicly traded company

Number of employees: 1,600 (2022)

Jazz Pharmaceuticals PLC is an American company established in 2003 that is famous for its therapies for rare diseases and sleep disorders. It is solely focused on developing life-changing medicine for those people who have serious diseases and have little to no options for them. Under the leadership of Bruce Cozadd, CEO, Jazz Pharma has managed to gain $9.90 billion of market capital.

11. Incyte Corp. (INCY)

CEO: Hervé Hoppenot

Founded In: 2002

Headquarters: Wilmington, Delaware, United States

Market Capital: 19.07 billion

Company Status: Publicly traded company

Number of employees: 2,094 (Dec 2021)

Incyte Corp. is an American company established in 2002 by merging two different companies: Incyte Pharmaceuticals and Incyte Genomics. It is famous for its therapies for cancer, autoimmune and inflammatory diseases. With a mid-size company and over 2094 employees, Incyte Corp. has a total market capital of $18.5 Billion and total revenue of $3.33 billion as of 2022. 

12. Novavax, Inc. (NVAX)

CEO: Stanley C. Erck

Founded In: 1987 

Headquarters: Gaithersburg, Maryland, United States

Market Capital: 959.39 million

Company Status: Publicly traded company

Number of employees: 1,541 (2022)

Novavax, Inc. is an American company established in 1987 that is famous for its vaccines for respiratory diseases and infectious diseases. With a mid-size company and 1,500 employees worldwide, Novavax, Inc. has a total market capitalization of $11.55 billion. Also, Novavax Inc is using the power and speed of nanoparticle technology for its vaccine technology.

13. Vir Biotechnology, Inc. (VIR)

CEO: Marianne De Backer

Founded In: April 7, 2016

Headquarters: San Francisco, California, United States

Market Capital: 4.11 billion

Company Status: Publicly traded company

Number of employees: 444 (dec 2021)

Vir Biotechnology, Inc. is an American company established in 2016 that is famous for its therapies for serious infectious diseases. It is a commercial-stage immunology company dedicated to treating and preventing serious infectious diseases by combining immunologic insights with cutting-edge technologies. With a mid-size company and 314 employees, Vir Biotechnology, Inc. has a total market capitalization of $3.67 billion.

14. BioMarin Pharmaceutical Inc. (BRMN)

CEO: Jean-Jacques Bienaime

Founded In: March 1997

Headquarters: Novato, California, United States

Market Capital: 21.79 billion

Company Status: Publicly traded company

Number of employees: 3,045 (Dec 2021)

BioMarin Pharmaceutical Inc. is an American company established in 1997 that is famous for its therapies for cancer, autoimmune and inflammatory diseases. With a mid-size company and 1,000 employees, Marin Pharmaceutical Inc. has a total market capital of $20.58 Billion and total revenue of $2 Billion Dollar as of January 2023.

15. Chugai Pharmaceutical Co.

CEO: Osamu Okada

Founded In: March 10, 1925

Headquarters: Chuo City, Tokyo, Japan

Market Capital: 44.51 billion USD

Company Status: Publicly traded company

Number of employees: 7,644 (Dec 2021)

Chugai Pharmaceutical Co. is a Japanese company established in 1925 that is famous for its therapies for cancer and other diseases. It is a subsidiary owned by Hoffamm-La Roche in 2002. With a large company size and 20 plus research sites and branches all over Japan, Chugai Pharmaceutical Co. has a total market capitalization of $40.92 billion.

16. Illumina

CEO: Francis deSouza

Founded In: 1998

Headquarters: San Diego, California, United States

Market Capital: 33.67 billion 

Company Status: Publicly traded company

Number of employees: 9,100 (Jan 2022)

Illumina is an American company established in 1998 that is famous for its DNA sequencing technology and genomic analysis. Illumina’s main mission is to improve human health by unlocking the power of the genome. Currently operating its research centers and sites in over 10 different countries, Illumina is redefining the meaning of possibility every single day. 

17. Lonza Pharmaceuticals

CEO: Pierre Alain Ruffieux

Founded In: 1897

Headquarters: Basel, Switzerland

Market Capital: 42.95 billion USD

Company Status: Publicly traded company

Number of employees: 17,000 approximately (present)

Lonza Pharmaceuticals is a Swiss company established in 1897 that is famous for its contract development and manufacturing services for the biotech industry. With a large company size and 17,000 employees, Lonza Pharmaceuticals has a total market capitalization of $39.17 billion. Currently, under Pierre-Alain Ruffieux’s leadership, Lonza Pharma recently launched a new capsule to deliver acid-sensitive active pharmaceutical ingredients to the intestine. 

18. WuXi AppTec

CEO: Steve Yang

Founded In: Dec 1, 2000

Headquarters: Shanghai, China

Market Capital: 42.32 billion USD

Company Status: Publicly traded company

Number of employees: 45,000 approximately (present)

WuXi AppTec is a Chinese company established in 2000 that is famous for its research and development services for the biotech industry. With a large company size and 45,000 employees, WuXi AppTec has a total market capitalization of $ 42.81 billion. WuXi APPTec has successfully developed itself from a laboratory of 700 sq. feet to 32 sites worldwide as of present.

19. Samsung Biologics

CEO: John Rim

Founded In: 2011

Headquarters: Incheon, South Korea

Market Capital: 46.81 billion USD

Company Status: publicly traded company

Number of employees: 4400+ (present)

Samsung Biologics is a South Korean company established in 2011 that is famous for its contract development and manufacturing services for the biotech industry. With a vision of enriching human life with technology and innovation, Samsung Biologics is the first contract manufacturing organization to obtain ISO 27001 certification in November 2019.

20. Agilent Technologies

CEO: Michael R. McMullen

Founded In: 1999

Headquarters: Santa Clara, California, United States

Market Capital: 46.10 billion usd

Company Status: publicly traded company

Number of employees: approximately 18,000

Agilent Technologies is an American company established in 1999 that is famous for its scientific instruments, software, and services for the life sciences, diagnostics, and applied chemical markets. Helping scientists across 110 countries worldwide in their research process, Agilent technologies have played a vital role in the advancement of the scientific instruments and applied chemical market.

21. Jiangsu Hengrui Medicine

CEO: Sun Piaoyang

Founded In: April 28, 1997

Headquarters: China

Market Capital: 40.94 billion usd

Company Status:  publicly traded company

Number of employees: 28,903 (2022)

Jiangsu Hengrui Medicine is a Chinese company established in 1970 that is famous for its research and development of innovative drugs. It mainly specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs. With its large infrastructure and 28,903 employees, Jiangsu Hengrui Medicine has a total market capitalization of $41.45 billion making it the 420th most valuable company on the market capitalization data.

22. WuXi Biologics

WuXi Biologics is a Chinese company established in 2015 that is famous for its contract development and manufacturing services for the biotech industry. With a vision of “ every drug can be made and every disease can be treated” WuXi Biologics has grown quite a lot in a short span of time compared to the other bio-techs in this list. It has a total market capitalization of $36.90 billion as of now and has successfully opened different manufacturing sites in Europe and North America.

23. Biogen

CEO: Michael Vounatsos

Founded In: 1987

Headquarters: Cambridge, Massachusetts, United States

Market Capital: 41.77 billion usd

Company Status: publicly traded company

Number of employees: 9,610 (dec 2021)

Biogen is an American company established in 1978 that is famous for its therapies for neurological disorders, multiple sclerosis, and rare diseases. Working more than 40 years in the medical industry, Biogen has a total market capitalization of $40.81 billion as of Jan 2023. The company currently operates in more than 80 different countries all over the world.

24. Sun Pharmaceutical Industries Ltd.

CEO: Dilip Shanghvi

Founded In: 1983

Headquarters: Goregaon, Mumbai, India

Market Capital: 30.5 billion usd

Company Status: publicly traded companies

Number of employees: 37,000+ (present)

Sun Pharmaceutical Industries Ltd. is an Indian company established in 1983 that is famous for its generic drugs and branded drugs for various therapeutic areas. With a large company size and 38,000 employees, Sun Pharmaceutical Industries Ltd. has a total market capital of $30.42 billion and total revenue of $5.1 billion. The company has more than 100 sites currently operating all across the globe.

25. Seagen

CEO: Roger Dansey

Founded In: July 15, 1997

Headquarters: Bothell, Washington, United States

Market Capital: 26.12 billion

Company Status: publicly traded companies

Number of employees: 2,675 (Dec 2021)

Seagen is an American company established in 1997 that is famous for its transformative therapies for cancer. They are driven by one single mission: to make a difference for people impacted by cancer. In the past year, Seagen made history in their 20 years tenure as their drug named “ TIVDAK” was approved by the U.S. making its fourth approved medicine in the line.

26. Genmab

CEO: Jan G. J. van de Winkel

Founded In: 1999

Headquarters: Copenhagen, Denmark

Market Capital: 25.6 billion USD

Company Status: publicly traded company

Number of employees: 1,212 (Dec 2021)

Genmab is a Danish company established in 1999 that is famous for its therapies for cancer, autoimmune and inflammatory diseases. With a mid-size company and 1,500 employees, Genmab has a total market capitalization of $26 million. Their core purpose is to provide aid to the lives of patients through innovative and differentiated antibody therapeutics.

27. UCB

CEO: Jean-Christrophe Tellier

Founded In: Jan 18, 1928

Headquarters: Brussels, Belgium

Market Capital: 14.45 billion (eur)

Company Status: publicly traded company

Number of employees: 5,001 – 10,000

UCB is a Belgian company established in 1928 that is famous for its therapies for neurological disorders, immunology, and rare diseases. They have spread all over the world establishing 40 sites and hiring 8600 people. With total revenue of €5.8 billion in 2021, they are proving their business game is as strong as their commitment to improving the lives of people.

28. Celltrion

CEO: Hyoung Ki Kim

Founded In: 2002

Headquarters: Incheon, South Korea 

Market Capital: 19.8 billion USD 

Company Status: publicly traded company

Number of employees: 2,145 (present)

Celltrion is a South Korean company established in 2002 that is famous for its biosimilars and therapeutic proteins. Currently employing 5,000 employees, Celltrion has a total market capitalization of $18.82 billion as of January 2023, and total revenue of $1.64 billion as of the financial reports 2021.

29. Charles River Laboratories

CEO:  James C. Foster

Founded In: 1947

Headquarters: Wilmington, Massachusetts, United States

Market Capital:12.47 billion

Company Status: publicly traded company

Number of employees: 20,000 (2021)

Charles River Laboratories is an American company established in 1947 that is famous for its research and development services for the pharmaceutical and biotech industries, including pre-clinical and clinical services. With 100 sites around the globe engaging 20,000 plus employees, Charles River Laboratories has a total market capitalization of $11.93 billion.

30. Sinopharm Group

CEO: Yong Liu

Founded In: 2003

Headquarters: China

Market Capital:19.8 billion USD

Company Status: publicly traded company

Number of employees: 128,000 (present)

Sinopharm Group is a Chinese company established in 2003 that is famous for its research, development, and manufacturing of pharmaceuticals, health products, and medical devices. Sinopharm Group is among the six listed companies that are owned by China National Pharmaceutical Group Co. Ltd (the parent company). The total market capitalization of Sinopharm is $8.11 billion.

Conclusion:

The biotech industry is constantly evolving and growing, with new companies and technologies emerging all the time. 

The companies listed above are just a few of the key players in the industry, and they are all making significant contributions to the field. 

From the development of personalized vaccines and therapies to the treatment of rare diseases, the biotech industry is helping to improve the lives of people around the world. 

With the rate at which technology is evolving and the increased focus on healthcare, it is safe to say that the biotech industry will continue to be a driving force in the world of science and medicine. 

With the above list of the top 30 biotech companies of 2023, the industry will have a clear understanding of the key players and their contributions.